DermAI to Evaluate Human Factor of Testing (NCT06387472) | Clinical Trial Compass
CompletedNot Applicable
DermAI to Evaluate Human Factor of Testing
United States151 participantsStarted 2024-05-08
Plain-language summary
The purpose of this research is to improve how well remote patch allergy testing works and make sure they are easy and practical for people to use from home.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- Willing and able to provide informed consent.
Exclusion Criteria:
* Has used topical or oral steroids two weeks prior to patch testing.
* Currently taking immunosuppression agents or is immunocompromised due to medical condition.
* No sunburn or rash at site of testing.
* Women who are breastfeeding or pregnant.
* Treatment with ultraviolet (UV) light (including tanning) during the two weeks prior to visit.
* Subjects unable to comply with patch test study requirements including multiple return visits and activity restrictions (e.g., protecting patch test area from excess moisture due to showering).